Finance entity
Every one of those 1 sits in a single category, earnings. Legend Biotech is most often covered alongside Core Molding Technologies, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window.
Last mentioned: Mar 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. Legend Biotech is most often covered alongside Core Molding Technologies, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.3 for that window. We currently track 1 Finance story that mention Legend Biotech, all published on March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 88 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Legend Biotech. Shared-story counts are live from our verified record — not editorial picks.
Legend Biotech and Core Molding Technologies released their full-year 2025 financial results, highlighting a period of strategic expansion and operational resilience. While Legend Biotech continues to scale its CAR-T therapy footprint, Core Molding demonstrated steady performance in the industrial manufacturing sector.
Legend Biotech is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
